• 2011

Company Description

AVT develops cancer therapeutics and immunotherapeutic vaccines that can be used together with prevalent treatment modalities.

AVT is primarily engaged in the business of developing Cancer Therapeutics and Immunotherapeutic Vaccines that can be used together with prevalent treatment modalities such as chemotherapy and radiation to treat active disease and to prevent metastases and recurrence.

  • Manufacturer:

    Science and Engineering
  • Formed:

    2011
  • Company Website:

  • Company E-mail:

  • Company Address:

    20 East 68th Street, Suite 204
    New York, NY
    United States
  • CEO:

    • Robert Pollock
  • We recognize our sponsors starting at $1 per entry.
    Learn more at https://www.ithistory.org/benefits